Us biotech firms line up for tax credits

Application process begins for cash to beat the downturn. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS

OPTIONS Access through your institution Subscribe to this journal Receive 51 print issues and online access $199.00 per year only $3.90 per issue Learn more Buy this article * Purchase on

SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about

institutional subscriptions * Read our FAQs * Contact customer support Authors * Heidi Ledford View author publications You can also search for this author inPubMed Google Scholar RELATED

LINKS RELATED LINKS RELATED LINKS IN NATURE RESEARCH Recession Watch RELATED EXTERNAL LINKS Investment Credit for Qualifying Therapeutic Discovery Projects Therapeutic Discovery Project

Program RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Ledford, H. US biotech firms line up for tax credits. _Nature_ 465, 854–855 (2010).

https://doi.org/10.1038/465854b Download citation * Published: 16 June 2010 * Issue Date: 17 June 2010 * DOI: https://doi.org/10.1038/465854b SHARE THIS ARTICLE Anyone you share the

following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer

Nature SharedIt content-sharing initiative